Bottom line
Is MEDI a good fund? The bottom line
MEDI is an actively managed health care sector ETF from Oakmark (Harris).
It charges 0.8% — about $80 a year on every $10,000 invested, cheaper than 61% of health care sector funds we track.
It returned +27.1% over one year (as of Dec 31, 2025, per its prospectus).
With $41.2 million in net assets and 44 holdings, its largest position is Eli Lilly & Co (20.8%) and the top 10 make up 59.7% of the portfolio.
What to watch
- Concentrated: top 10 holdings are 59.7% of assets
- Small fund ($41.2 million) — small funds are likelier to close
- High turnover (167% a year) can mean more taxable distributions
Updated Nov 19, 2026
What MEDI invests in
The Fund seeks long-term growth of capital.
The Fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (health care companies). Health care companies may include, for example, manufacturers of health care equipment and supplies, health care services providers, pharmaceutical companies, biotechnology and life sciences companies, and suppliers of technologies for use by health care companies. The Fund may invest in issuers of all market capitalizations, including larger, established issuers and newer companies with little or no current revenues. The Fund may invest in foreign…
From the fund's prospectus (filed Feb 27, 2026).
MEDI performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MEDI | +27.1% | — | — |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What MEDI costs
On a $10,000 investment, MEDI's 0.8% expense ratio costs about $80 a year. The prospectus estimates $990 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
MEDI top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co | 20.78% |
| 2 | Ascendis Pharma A/S | 13.61% |
| 3 | Gilead Sciences Inc | 5.10% |
| 4 | Rhythm Pharmaceuticals Inc | 4.02% |
| 5 | AbbVie Inc | 3.09% |
| 6 | Intuitive Surgical Inc | 2.83% |
| 7 | Cencora Inc | 2.75% |
| 8 | Revolution Medicines Inc | 2.54% |
| 9 | Insmed Inc | 2.52% |
| 10 | Merck & Co Inc | 2.47% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 59.7% of the fund. See all top 25 holdings and asset mix →